Medicines Patent Pool Director Ellen ‘t Hoen To Leave Next Month 16/04/2012 by William New, Intellectual Property Watch 2 Comments Executive Director Ellen ‘t Hoen is departing the Medicines Patent Pool, the cutting edge UN spin-off project that works to lower prices on and stimulate new development of HIV medicines and other products through negotiating voluntary licence agreements. According to a release, ‘t Hoen has fulfilled the mission of guiding the organisation from a startup onto “firm footing” and has informed the Board that she will leave on 1 May.
‘Counterfeit’ Dropped From New WHO Protocol On Illicit Tobacco Trade 04/04/2012 by William New, Intellectual Property Watch 1 Comment A new treaty protocol against illicit trade in tobacco products struck today at the World Health Organization saw a late-stage decision to strip out references to “counterfeit” products from the text, according to sources.
WHO / EU “Bad Medicine” Plans: Flaws, Coordination Gaps 02/04/2012 by Intellectual Property Watch 2 Comments The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws, Daniele Dionisio writes.
Global Fund Changes Continue As West Africa Team Leader Departs 23/03/2012 by William New, Intellectual Property Watch 1 Comment The head of the West Africa region for the Global Fund to Fight AIDS, Tuberculosis and Malaria is the next in the line of departures under the organisation’s reforms. On the way out, he sent around a passionate farewell email calling for a dedication to values, and offering a small window on the wrenching transition taking place inside the international organisation.
WHO Head Urges Global Support For Australia In Fight Against Tobacco 22/03/2012 by William New, Intellectual Property Watch 1 Comment World Health Organization Director-General Margaret Chan has issued a call for global support of Australia in defending its “plain packaging” tobacco law against an onslaught of legal challenges from the tobacco industry. The industry has cited trademark concerns as a top issue.
Intérêt de l’entreprise et choix stratégiques : les licences concédées par Gilead au Medicines Patent Pool 14/03/2012 by Intellectual Property Watch Leave a Comment Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.
WHO Under Siege By Private Sector, Group Asserts 13/03/2012 by Intellectual Property Watch Leave a Comment The World Health Organization is under siege by private sector forces using their financial leverage to gain undue influence in the financially beleaguered United Nations agency, a developing country-oriented group has said.
The Pulse Of IP In International Pharma Today 24/02/2012 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment High-level policymakers, industry leaders, law professors and other stakeholders came together in Geneva recently to discuss the how the role of intellectual property is evolving when it comes to developing, protecting, and providing medicines.
WHO Group Keeps Lid On Bird Flu Lab Results – For Now 17/02/2012 by Intellectual Property Watch 1 Comment A group of public health experts gathered by the World Health Organization agreed today to continue a moratorium on research done on the H5N1 bird flu virus modified in a laboratory to be more transmissible between mammals. But they said research should continue on the naturally occurring version of the virus.
Public Health In 2012: A Busy Crossroads Of Partnership, Innovation, And Trade 17/02/2012 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment From advancing public-private partnerships and increasing international collaboration to promoting innovation in neglected therapy areas and developing new research and development models, policymakers have set a steady pace as they advance the 2012 global health agenda.